Evaluation of S-[ 11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites
The biologically active S-enantiomer of [ N-methyl- 11C]citalopram was evaluated as a radioligand for in vivo labelling of the 5-hydroxytryptamine uptake site in brain, using ex vivo tissue counting in rats and positron emission tomography in man. In rats, the maximal signal for total versus non-spe...
Gespeichert in:
Veröffentlicht in: | International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology Nuclear medicine and biology, 1992-11, Vol.19 (8), p.851-855 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The biologically active
S-enantiomer of [
N-methyl-
11C]citalopram was evaluated as a radioligand for
in vivo labelling of the 5-hydroxytryptamine uptake site in brain, using
ex vivo tissue counting in rats and positron emission tomography in man. In rats, the maximal signal for total versus non-specific binding was approx. 2 at 60–120 min after radioligand injection. Subsequent studies in man failed to identify a specific signal over a 90 min scanning period, due to prolonged retention of non-specific label. |
---|---|
ISSN: | 0883-2897 |
DOI: | 10.1016/0883-2897(92)90171-T |